Clinical trial
Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus
NCT00407069 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00407069 |
|---|---|
| Title | Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus |
| Official title | Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (ADVN AMP01) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Atopic Dermatitis |
| Enrollment | 286 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Dec 4, 2006 |
| Last update posted | Oct 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: